28 June 2022 Pretoria – The South African Health Products Regulatory Authority (SAHPRA) initially signed a Memorandum of Understanding (MOU) with the South African National Accreditation System (SANAS) in 2017 and this will now be extended in 2022. This MOU will now also incorporate the following activities...
Embargo: Immediate release Pretoria, 24 June 2022 – The South African Health Products and Regulatory Authority (SAHPRA) registered the COVID-19 vaccine, Coronavac, on 14 June 2022, with conditions. The registration was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101 of...
Embargo: Immediate release Pretoria, 23 June 2022 – SAHPRA has registered a new “sweet-tasting” combination antiretroviral treatment for infants and young children with HIV. This treatment comes in granules that can be sprinkled on soft food or dissolved in milk or water. Furthermore, this treatment does...
23 June 2022 The South African Health Products Regulatory Authority (SAHPRA) has been making strides in the use of the Med Safety App that reports on the Adverse Events Following Immunisation (AEFIs) and this is being noticed within the continent. SAHPRA has been working in conjunction with...
SamuelFrancisJohnson via Pixabay...
17 June 2022 CEO Perspectives and Horizons as Covid-19 takes a grip The SAHPRA CEO, Dr Boitumelo Semete-Makokotlela shares her journey since she assumed the position of CEO. She unpacks how she had to face a “sink or swim” situation as the COVID-19 pandemic gripped South Africa...
07 June 2022 Embargo: Immediate release1. The COVID-19 vaccine LHC has been registered with conditions on 24 May 2022.The registration of the COVID-19 vaccine LHC was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101 of 1965. This COVID-19 vaccine (Sinopharm...
30 May 2022 Embargo: Immediate release Pretoria, 30 May 2022 - The use of Ivermectin for the treatment and prevention of COVID-19 received a lot of public interest in 2020. Early evidence, mostly from studies with a small number of patients and conducted with varying degrees...
27 May 2022 Embargo: Immediate release On 7 May 2022, the South African Health Products Regulatory Authority (SAHPRA) published a statement indicating that it would join the Minister of Health in approaching the Constitutional Court for leave to appeal the Supreme Court of Appeal (SCA) judgement...
17 May 2022 At a four-day meeting at the Paul-Ehrlich-Institut, representatives of the regulatory authorities in Ghana (Food and Drugs Authority, FDA), Rwanda (Food and Drugs Authority, FDA), South Africa (South African Health Products Regulatory Authority, SAHPRA) and Senegal (Agence sénégalaise de Réglementation Pharmaceutique, ARP) discussed future cooperation with vaccine...
